K Jaffal, B Davido - La Presse Médicale Formation, 2023 - Elsevier
Points essentiels Les mesures barrières (gestes et vaccination) constituent un axe majeur de la prévention individuelle et collective contre la Covid-19. Les antibiotiques n'ont pas leur …
Pratique en vigueur: La pratique actuellement suivie pour traiter la COVID-19 est variable, ce qui témoigne d'un degré d'incertitude élevé. De nombreux essais contrôlés randomisés …
A Murgadella-Sancho, B Gracia-García… - Farmacia …, 2021 - Elsevier
Objective To describe the effectiveness and safety of remdesivir in patients with SARS-CoV- 2 pneumonia in real-world clinical practice conditions. Method Retrospective observational …
RS Alibrahim, EZ Elmekaty, MZI Elmekaty… - Qatar Medical …, 2022 - qscience.com
Background: Treatment options for patients with critical Coronavirus Disease 2019 (COVID- 19) are limited. This study aimed to describe the clinical characteristics and outcomes …
Objective We systematically reviewed the evidence of published original research to determine the role of remdesivir in the management of patients with COVID-19 and a …
K Jaffal, B Davido - Revue des maladies respiratoires, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction There now exist preventive and curative treatments available for both early and advanced stages of COVID-19 management. Current knowledge Antibiotics have no place …
F Ader, M Bouscambert-Duchamp, M Hites… - The Lancet infectious …, 2022 - thelancet.com
Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial. We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …
F Ader, M Bouscambert-Duchamp, M Hites… - medRxiv, 2022 - medrxiv.org
Background The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating its clinical effectiveness in hospitalised patients with COVID-19, with indication of oxygen …
A Murgadella-Sancho, B Gracia-García… - Farmacia …, 2021 - SciELO Espana
MURGADELLA-SANCHO, Anna et al. Experience in the use of remdesivir in patients with SARS-CoV-2 pneumonia. Farm Hosp.[online]. 2021, vol. 45, n. 5, pp. 253-257. Epub 16-Ene …